Larry P. Naughton

  • Represented a robotics developer in its sale to a NASDAQ-listed company, a transaction that was named “Cross Border Healthcare/Life Sciences Deal of the Year” by The M&A Advisor.
  • Represented a management team in conducting a buyout from a leading private equity fund.
  • Represented various venture capital firms in numerous financings of life sciences and technology companies.
  • Represented a European technology company in its sale to a Fortune 500 company.
  • Represented a wealth management firm in its acquisition of a leading competitor.
  • Represented a venture capital firm in its formation of successive investment partnerships.
  • Represented a founder-owned digital asset management company in its sale to a multinational private equity firm.
  • Represented a cybersecurity company in its equity financing.
  • Represented a digital media company in its formation and through multiple rounds of financings to fund operations in China.
  • Represented an e-commerce analytics company from formation through eventual sale to a global technology company.
  • Represented a European-based software company in its acquisition of technology from Microsoft IP Ventures.
  • Advised a UK-based private-equity backed company in its acquisition of a US company to launch its US operations.
  • Represented a provider of cloud-based warehouse management solutions in its sale to a Fortune 500 company.
  • Represented a French-based consulting firm in its acquisition of US-based consulting firm.
  • Represented a food manufacturer listed on the London Stock Exchange in connection with various acquisition activities in the United States.
  • Represented a European-based FinTech company in its US activities, including acquisition and strategic investment transactions.
  • Represented a venture capital–backed developer of life sciences compliance software solutions in its sale to a NASDAQ-listed company.
  • Represented an online marketplace in formation and multiple rounds of equity financings.
  • Represented a European-based developer of CRO applications in multiple acquisitions of US-based companies.
     
Mintz Advises Vicarious Surgical in $1.1 Billion SPAC Merger Case Study

Mintz Advises Vicarious Surgical in $1.1 Billion SPAC Merger

Mintz is advising Vicarious Surgical Inc., a robotics company developing technology that combines human-like surgical robots and virtual reality to perform minimally invasive surgery, in a pending merger with special purpose acquisition company D8 Holdings Corp. that is expected to deliver up to $460 million in gross proceeds.